FIELD: pharmaceuticals.
SUBSTANCE: group of inventions relates to the field of pharmaceuticals, namely to an antiviral humic agent and its use for the treatment and/or prevention of viral diseases. Antiviral humic agent is obtained from leonardite, lignin, coal, peat, sapropel by ultrasonic dispersion of pre-crushed raw materials in a mixture with water at a certain temperature and a certain pressure, after which the solution is cooled to room temperature and diluted with water to a content of humic substances ranging from 1 to 20 wt. % , while humic substances include humic and fulvic acids and their salts, as well as hydroquinone in an amount not exceeding 3 wt. % of the mass of humic substances.
EFFECT: production of an antiviral humic agent containing a wide range of humic substances and having no chemical impurities, which can be used in the field of medicine and pharmacy.
2 cl, 4 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ADAPTOGENIC HUMIC AGENT | 2021 |
|
RU2775079C1 |
| ANTIBACTERIAL HUMIC AGENT | 2020 |
|
RU2753606C1 |
| ANTI-INFLAMMATORY HUMIC AGENT | 2020 |
|
RU2756363C1 |
| HEPATOPROTECTIVE HUMIC AGENT | 2021 |
|
RU2763761C1 |
| IMMUNOMODULATING HUMIC AGENT | 2020 |
|
RU2756353C1 |
| DETOXIFYING HUMIC AGENT | 2020 |
|
RU2756354C1 |
| ANTIVIRAL AGENT BASED ON DRY EXTRACT OF FRUIT BODY OF BASIDIOMYCETE Coprinus comatus | 2015 |
|
RU2584751C1 |
| ANTICOAGULATION HUMIC AGENT FOR IMPROVING RHEOLOGICAL PROPERTIES OF BLOOD | 2020 |
|
RU2756364C1 |
| METHODS OF PREVENTION AND TREATMENT OF DISEASES CAUSED BY A/H5N1 BIRD INFLUENZA VIRUS WITH USING INTERFERON INDUCER AND NEURAMINIDASE INHIBITOR | 2008 |
|
RU2398596C2 |
| ANTIVIRAL AGENT BASED ON HUMIC ACIDS | 2018 |
|
RU2678986C1 |
